Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AnalytiCon Discovery GmbH
Deal signed to identify natural compounds for Johnson & Johnson
August 10th, 2005
AnalytiCon Discovery GmbH, a specialist in all aspects of natural product drug discovery, announced it has signed an agreement that will provide Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V. (J&JPRD), with full access to the unique chemical diversity contained within AnalytiCon's extensive natural products biological collection. Financial terms of the agreement were not disclosed. According to the agreement, AnalytiCon will apply its proprietary MEGAbolite technology to isolate and characterize small molecule compounds from a variety of biosources to .nd novel and pharmaceutically active compounds on...
Source: Biotech Week (2005-08-10)
|
